Working Hours
Mon - Sat 9:00 - 6:00
Price:
Price 169.0 INR / Piece
Minimum Order Quantity : 50 Pieces
Quantity : 50 Pieces
Ingredients : Brand Name: CEFACTAM FORTE Generic Name / Content: Cefoperazone & Sulbactam for Injection 1.5 g Company: Aurobindo Pharma Ltd CEFACTAM FORTE 1.5 g Injection is a combination antibiotic containing Cefoperazone (a thirdgeneration cephalosporin) and Sulbactam (a betalactamase inhibitor). This dualaction formulation provides broadspectrum antibacterial coverage and is effective against betalactamase producing organisms. Cefoperazone works by inhibiting bacterial cell wall synthesis, while Sulbactam enhances its activity by preventing enzymatic degradation. The injection is intended for intravenous (IV) or intramuscular (IM) administration in hospital and clinical settings. Indications Lower and upper respiratory tract infections Urinary tract infections (UTIs) Intraabdominal infections Skin and soft tissue infections Bone and joint infections Septicemia and bacteremia Gynecological infections Key Features Thirdgeneration cephalosporin with betalactamase inhibitor Broadspectrum antibacterial activity Effective against resistant organisms Sterile injectable formulation Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial) Category: Injectable / Parenteral Antibiotic Strength: 1.5 g per vial Content: Cefoperazone + Sulbactam Packaging & Storage Supplied in sterile vial packaging Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision
Drug Type : Other, Allopathic
Physical Form : Other
Price 283.0 INR / Pair
Minimum Order Quantity : 50 Pairs
Quantity : 1 vial Boxes
Ingredients : Brand Name: AURACT 1 G Injection Generic Name / Content: Ceftriaxone Sodium Injection I.P. 1 AURACT 1 G Injection contains Ceftriaxone Sodium, a thirdgeneration cephalosporin antibiotic with broadspectrum activity against Grampositive and Gramnegative bacteria. It is widely used for the treatment of serious bacterial infections in hospital and clinical settings. Ceftriaxone works by inhibiting bacterial cell wall synthesis, leading to bacterial death. This injectable formulation is suitable for intravenous (IV) or intramuscular (IM) administration under medical supervision. Indications Respiratory tract infections (pneumonia, bronchitis) Urinary tract infections (UTIs) Skin and soft tissue infections Septicemia and bacteremia Bone and joint infections Meningitis Gonorrhea and other sexually transmitted infection Key Features Thirdgeneration cephalosporin antibiotic Broadspectrum antibacterial activity Rapid and effective action Sterile injectable form for IV or IM use Suitable for adults and pediatric patients (as prescribed) Dosage Form & Category Dosage Form: Injection (Vial / Ampoule) Category: Injectable / Parenteral Strength: 1 g per vial Content: Ceftriaxone Sodium I.P. Packaging & Storage Supplied in sterile vials Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision
Drug Type : Injection
Physical Form : Other
Price 242.0 INR / Vial
Minimum Order Quantity : 50 Vials
Quantity : 50 Pieces
Ingredients : Brand Name: CEFTRAX 1.125 TZ Generic Name / Content: Ceftriaxone + Tazobactam Injection I.P. 1.125 g Company: Aurobindo Pharma Ltd CEFTRAX 1.125 TZ Injection is a combination antibiotic containing Ceftriaxone (a thirdgeneration cephalosporin) and Tazobactam (a betalactamase inhibitor). This dualaction formulation provides broadspectrum antibacterial activity, including efficacy against betalactamase producing bacteria. Ceftriaxone inhibits bacterial cell wall synthesis, while Tazobactam prevents enzymatic degradation of the antibiotic, enhancing overall effectiveness. This sterile injectable formulation is suitable for intravenous (IV) or intramuscular (IM) administration in hospitals and clinical settings. Indications Severe respiratory tract infections (pneumonia, bronchitis, sinusitis) Urinary tract infections (UTIs) Skin and soft tissue infections Bone and joint infections Intraabdominal infections Septicemia and bacteremia Gynecological infections Surgical prophylaxis Key Features Thirdgeneration cephalosporin combined with a betalactamase inhibitor Broadspectrum antibacterial coverage Effective against resistant bacterial strains Sterile injectable formulation for IV or IM use Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial) Category: Injectable / Parenteral Antibiotic Strength: 1.125 g per vial Content: Ceftriaxone + Tazobactam Packaging & Storage Supplied in sterile vial packaging Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision
Drug Type : Injection
Physical Form : Liquid
Price 354.0 INR / Box
Minimum Order Quantity : 50 Boxes
Quantity : 50 Boxes
Ingredients : Brand Name: LIN+IV 600 mg Tablet Generic Name / Content: Linezolid Tablet I.P. 600 mg Company: Aurobindo Pharma Ltd LIN+IV 600 mg Tablet contains Linezolid, a synthetic oxazolidinoneclass antibiotic used for the treatment of serious Grampositive bacterial infections. It works by inhibiting bacterial protein synthesis, effectively stopping the growth and multiplication of susceptible bacteria. This oral formulation is suitable for patients requiring outpatient therapy or for hospital use when intravenous therapy is not needed. Indications Complicated skin and soft tissue infections Communityacquired pneumonia (CAP) Hospitalacquired pneumonia (HAP) Infections caused by methicillinresistant Staphylococcus aureus (MRSA) Vancomycinresistant Enterococcus faecium (VRE) infections Key Features Oxazolidinoneclass broadspectrum antibiotic Effective against multidrugresistant Grampositive bacteria Oral tablet formulation for easy administration Rapid onset of action Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Tablet Category: Oral Antibiotic (Oxazolidinone Class) Strength: 600 mg Content: Linezolid I.P. Packaging & Storage Supplied in blister packs or bottles as per packaging Store in a cool, dry place below 25 C Protect from light and moisture Use under qualified medical supervision
